SCHEMBL5657934

SCHEMBL5657934

COc1cccc(CCCl)c1O

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.65
PTGS2 P35354 1/20 0.65
IDO1 P14902 1/20 0.57
MAPT P10636 6/20 0.53
ALDH1A1 P00352 5/20 0.53
KDM4E B2RXH2 3/20 0.53
HPGD P15428 3/20 0.53
CYP3A4 P08684 2/20 0.53
ALOX15 P16050 2/20 0.53
LMNA P02545 2/20 0.53
ALOX12 P18054 2/20 0.53
TP53 P04637 1/20 0.53
MAPK1 P28482 1/20 0.53
HSD17B10 Q99714 1/20 0.53
CALM1 P0DP23 1/20 0.53
GAA P10253 7/20 0.49
GFER P55789 1/20 0.49
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
NPSR1 Q6W5P4 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7393700 0.85 ALOX5 (0.46) ALOX5PTGS2IDO1MAPTALDH1A1
SCHEMBL23748452 0.83 ALOX5 (0.77) ALOX5PTGS2IDO1MAPTALDH1A1
SCHEMBL16088316 0.81 TAAR1 (0.67) ALOX5PTGS2IDO1MAPTALDH1A1
SCHEMBL6054608 0.80 TAAR1 (0.64) IDO1MAPTALDH1A1GAACA12
SCHEMBL59746 0.80 ALOX5 (0.90) ALOX5PTGS2IDO1MAPTALDH1A1
Hydrochloric Acid SCHEMBL16037890 0.80 IDO1 (0.65) ALOX5PTGS2IDO1MAPTALDH1A1
SCHEMBL29365570 0.80 ALOX5 (0.90) ALOX5PTGS2IDO1MAPTALDH1A1
SCHEMBL9049552 0.80 GABRA1 (0.50) ALOX5PTGS2ALDH1A1HPGDALOX15
SCHEMBL10501385 0.79 CA12 (0.54) MAPTALDH1A1KDM4ECYP3A4MAPK1
SCHEMBL7210177 0.79 ALOX5 (0.87) ALOX5PTGS2IDO1MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7294715-B2 Aporphine and oxoaporphine compounds and pharmaceutical use thereof LOTUS PHARMACEUTICAL CO., LTD. (TW) 2007-11-13 US disclosed
US-20060211723-A1 Aporphine and oxoaporphine compounds and pharmaceutical use thereof LOTUS PHARMACEUTICAL CO., LTD. (TW) 2006-09-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060211723-A1 Aporphine and oxoaporphine compounds and pharmaceutical use thereof OGFRL1, THOP1, APOL1 ALOX5 782/4885PTGS2 1378/4885IDO1 503/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.